Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk

Cancer Genetics and Cytogenetics

Volumn 169, Issue 2, 2006, Pages 89-93

  Acar, Hasan ^a   Ozturk, Kayhan ^a   Muslumanoglu, M Hamza ^b   Yildirim, M Selman ^a   Cora, Tulin ^a   Cilingir, Oguz ^b   Ozer, Bedri ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; XENOBIOTIC AGENT;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DETOXIFICATION; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RISK FACTORS; SMOKING;

EID: 33747841616     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.12.007     Document Type: Article

References (19)

1. Ai H., Barrera J.E., Pan Z., Meyers A.D., and Varella-Garcia M. Identification of individuals at high risk for head and neck carcinogenesis using chromosome aneuploidy detected by fluorescence in situ hybridization. Mutat Res 439 (1999) 223-232
2. Dong Y., Sui L., Watanabe Y., Sugimoto K., and Tokuda M. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Lett 177 (2002) 13-19
3. Rafferty M.A., Fenton J.E., and Jones A.S. The history, aetiology and epidemiology of laryngeal carcinoma. Clin Otolaryngol Allied Sci 26 (2001) 442-446
4. Szyfter K., Szmeja Z., Szyfter W., Hemminki K., Banaszewski J., Jaskula-Sztul R., and Louhelainen J. Molecular and cellular alterations in tobacco smoke-associated larynx cancer. Mutat Res 445 (1999) 259-274
5. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 (2000) 256-263
6. To-Figueras J., Gene M., Gomez-Catalan J., Pique E., Borrego N., Caballero M., Cruellas F., Raya A., Dicenta M., and Corbella J. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 187 (2002) 95-101
7. Unal M., Tamer L., Ates N.A., Akbas Y., Pata Y.S., Vayisoglu Y., Ercan B., Gorur K., and Atik U. Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 25 (2004) 318-322
8. Gronau S., Koenig-Greger D., Jerg M., and Riechelmann H. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?. Otolaryngol Head Neck Surg 128 (2003) 674-680
9. Schneider J., Bernges U., Philipp M., and Woitowitz H.J. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 208 (2004) 65-74
10. Nazar-Stewart V., Vaughan T.L., Stapleton P., Van Loo J., Nicol-Blades B., and Eaton D.L. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 40 (2003) 247-258
11. Choi S.C., Yun K.J., Kim T.H., Kim H.J., Park S.G., Oh G.J., Chae S.C., Oh G.J., Nah Y.H., Kim J.J., and Chung H.T. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett 195 (2003) 169-175
12. Katoh T., Nagata N., Kuroda Y., Itoh H., Kawahara A., Kuroki N., Ookuma R., and Bell D.A. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17 (1996) 1855-1859
13. Kihara M., Kihara M., Kubota A., Furukawa M., and Kimura H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett 112 (1997) 257-262
14. Konig-Greger D., Riechelmann H., Wittich U., and Gronau S. Genotype and phenotype of glutathione-S-transferase in patients with head and neck carcinoma. Otolaryngol Head Neck Surg 130 (2004) 718-725
15. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., and Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85 (1993) 1159-1164
16. Wiencke J.K., Pemble S., Ketterer B., and Kelsey K.T. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4 (1995) 253-259
17. Jin C., Jin Y., Wennerberg J., Dictor M., and Mertens F. Nonrandom pattern of cytogenetic abnormalities in squamous cell carcinoma of the larynx. Genes Chromosomes Cancer 28 (2000) 66-76
18. De Stefani E., Boffetta P., Deneo-Pellegrini H., Brennan P., Correa P., Oreggia F., Ronco A.L., and Mendilaharsu M. Supraglottic and glottic carcinomas: epidemiologically distinct entities?. Int J Cancer 112 (2004) 1065-1071
19. Smit C.F., Mathus-Vliegen L.M., Devriese P.P., Schouwenburg P.F., and Kupperman D. Diagnosis and consequences of gastropharyngeal reflux. Clin Otolaryngol Allied Sci 25 (2000) 440-455